CRISPR Therapeutics
CRSP
$56.41
Share price
1.35%
Change (1 day)
10.43%
Change (1 year)
CRISPR Therapeutics (CRSP) - Total debt
Total debt on the balance sheet as of December 2023 : $0.23 B
According to CRISPR Therapeutics's latest financial reports the company's total debt is $0.23 B. A company’s total debt is the sum of all current and non-current debts.
CRISPR Therapeutics - Total debt on balance sheet (from 2015 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.23 B | -2.21% |
| 2022-12-31 | $0.24 B | 8.44% |
| 2021-12-31 | $0.22 B | 266.33% |
| 2020-12-31 | $61.42 M | 16.92% |
| 2019-12-31 | $52.53 M | |
| 2018-12-31 | $N/A | |
| 2015-12-31 | $38.33 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | -98.85% | 🇺🇸 USA |